Cero Therapeutics Holdings Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,380 | -10,523 | -5,106 | -8,304 | -8,976 |
| Depreciation Amortization | 810 | 537 | 270 | 1,162 | 881 |
| Accounts payable and accrued liabilities | 1,426 | 562 | 728 | 259 | -232 |
| Other Working Capital | 96 | -434 | -70 | 1,837 | 599 |
| Other Operating Activity | 773 | 790 | -267 | -7,869 | -3,647 |
| Operating Cash Flow | $-12,274 | $-9,069 | $-4,446 | $-12,916 | $-11,376 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 500 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $500 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 408 | 408 |
| Debt Repayment | N/A | N/A | N/A | -20 | -20 |
| Common Stock Issued | 4,273 | 4,273 | 4,990 | N/A | 14 |
| Common Stock Repurchased | N/A | N/A | N/A | 4,810 | N/A |
| Other Financing Activity | 6,196 | 4,771 | 1,332 | 8,530 | 11,839 |
| Financing Cash Flow | $10,469 | $9,044 | $6,322 | $13,728 | $12,241 |
| Beginning Cash Position | 3,327 | 3,327 | 3,327 | 3,479 | 3,479 |
| End Cash Position | 2,022 | 3,303 | 5,204 | 4,291 | 4,344 |
| Net Cash Flow | $-1,305 | $-24 | $1,877 | $812 | $865 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,274 | -9,069 | -4,446 | -12,916 | -11,376 |
| Free Cash Flow | -12,274 | -9,069 | -4,446 | -12,916 | -11,376 |